To access this element change to forms mode OFF
Grant Award View - GA353573
Improving outcomes in high risk cancer patients through rational...
GA ID:
GA353573
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
24-Aug-2023
Publish Date:
22-Jan-2024
Category:
Medical Research
Grant Term:
1-Jan-2024 to 31-Dec-2028
Value (AUD):
$511,050.10
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 22/23 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Improving outcomes in high risk cancer patients through rational antimicrobial use
Purpose:
Life threatening infection frequently occurs in patients with low white blood cells following chemotherapy for blood cancer and bone marrow transplants. Antibiotics can be life-saving, but fever is not always infection and we know that prolonged antibiotics are associated with poor outcomes such as developing antibiotic-resistant infections. This program will study cutting-edge new diagnostic tests and clinical trials of antibiotic cessation to reduce antibiotic use.
GO ID:
GO Title:
Investigator Grants 2023
Internal Reference ID:
2023/GNT2026083
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA